Literature DB >> 9111038

Can enzymatic activity, or otherwise, be inferred from structural studies of annexin III?

B Perron1, A Lewit-Bentley, B Geny, F Russo-Marie.   

Abstract

Annexin III, a putative inositol (1,2)-phosphohydrolase, was co-crystallized with inositol 2-phosphate, the inhibitor of the reaction, and its structure was solved to 1.95 A resolution. No enzyme active site was observed in the structure. Assays for enzymatic activity were also negative. Search for annexin III-inositol phosphate interactions using the BIAcoreTM system revealed an affinity for inositol cyclic (1,2)-phosphate, suggesting annexin III may sequester the molecule in the cell. The BIAcoreTM system used with different phospholipids showed that annexin III displays specificity for phosphatidylethanolamine, but not for phosphatidylinositols. Interestingly, a molecule of ethanolamine was found bound to the protein in the crystal structure. Coupled with the fact that this is a particularly abundant phospholipid in granules specific to neutrophils, cells where annexin III is highly expressed, our finding could be pointing to a physiological role of annexin III.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9111038     DOI: 10.1074/jbc.272.17.11321

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  The role of annexin A3 playing in cancers.

Authors:  Na Wu; Shuqing Liu; Chunmei Guo; Zhijie Hou; Ming-Zhong Sun
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

2.  Annexin A3 Is a Potential Predictor of Platinum Resistance in Epithelial Ovarian Cancer Patients in a Prospective Cohort.

Authors:  Ying Jin; Li-Ping Feng; Xiang Jiang; Yong-Xue Wang; Jie Yin; Zi-Ping Yang; Yan Li; Ling-Ya Pan
Journal:  J Cancer       Date:  2015-06-10       Impact factor: 4.207

3.  Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth.

Authors:  Ke Wang; Jiansheng Li
Journal:  Oncotarget       Date:  2016-12-27

4.  Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells.

Authors:  Limin Wang; Xueqin Li; Yinghui Ren; Hua Geng; Qicheng Zhang; Limin Cao; Zhaowei Meng; Xiang Wu; Meilin Xu; Ke Xu
Journal:  Cancer Sci       Date:  2019-04-09       Impact factor: 6.716

5.  Investigation of type I interferon responses in ANCA-associated vasculitis.

Authors:  Isabella Batten; Mark W Robinson; Arthur White; Cathal Walsh; Barbara Fazekas; Jason Wyse; Antonia Buettner; Suzanne D'Arcy; Emily Greenan; Conor C Murphy; Zoe Wigston; Joan Ní Gabhann-Dromgoole; Edward M Vital; Mark A Little; Nollaig M Bourke
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

6.  Identification of a Four-Gene Signature for Diagnosing Paediatric Sepsis.

Authors:  Yinhui Yao; Jingyi Zhao; Junhui Hu; Hong Song; Sizhu Wang; Ying Wang
Journal:  Biomed Res Int       Date:  2022-02-14       Impact factor: 3.411

7.  Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.

Authors:  Ruikai Du; Bingjie Liu; Lei Zhou; Dong Wang; Xueyan He; Xiaojun Xu; Lixing Zhang; Chaoshi Niu; Suling Liu
Journal:  Cell Death Dis       Date:  2018-01-26       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.